中医药对脓毒症Th17/Treg免疫功能障碍影响的研究进展
李鹤然;梁群;刘洋;刘雨默;于佳琪;
摘要(Abstract):
脓毒症的主要发病机制是免疫应答失控。脓毒症时免疫亢进与免疫抑制同时存在,Th17细胞和Treg细胞是免疫系统的重要组成部分,在维持免疫稳态方面起着至关重要的作用。大量实验与临床均证明Th17/Treg免疫失衡与脓毒症发病和病程进展严重程度密切相关。中医药作为脓毒症防治领域的新途径,具有独特的优势。本文主要介绍中医药对脓毒症Th17/Treg免疫功能障碍影响的研究进展。
关键词(KeyWords): 脓毒症;Th17;Treg;Th17/Treg;中医药;综述
基金项目(Foundation): 国家自然科学基金面上项目(81974557);; 国家中医药管理局新冠肺炎中医药应急专项课题(2020ZYLCYJ 06-2)
作者(Authors): 李鹤然;梁群;刘洋;刘雨默;于佳琪;
参考文献(References):
- [1]Victor VM,Espulgues JV,Hernandez-Mijares A,et al.Oxidative stress and mitochondrial dysfunctioninsepsis:apotential therapywithmitochondria-targeted antioxidants[J].Infect Disord Drug Targets,2009,9(4):376-89.
- [2]Coakley JD,Breen EP,Moreno-Olivera A,et al.Dysregulated T helper type 1(Th1)and Th17 responses in elderly hospitalised patients with infection and sepsis[J].PLo S One,2019,14(10):e0224276.
- [3]Zhang W.,Liu X.,Zhu Y.,et al.Transcriptional and posttranslational regulation of Th17/Treg balance in health and disease[J].European Journal of Immunology,2021,51(9),2137-2150.
- [4]Liu Z,Liu L,Zhong Y,et al.Lnc RNA H19 over-expression inhibited Th17 cell differentiation to relieve endometriosis through mi R-342-3p/IER3 pathway[J].Cell Biosci,2019,9(1):84-93.
- [5]Marques HS,de Brito BB,da Silva FAF,et al.Relationship between Th17 immune response and cancer[J].World J Clin Oncol,2021,12(10):845-867.
- [6]葛育文,张宁.Th17/Treg失衡在不明原因复发性自然流产中的作用[J].医学综述,2021,28(16):3167-3172.
- [7]Xia H,Wang F,Wang M,et al.Maresin1 ameliorates acute lung injury induced by sepsis through regulating Th17/Treg balance[J].Life Sci,2020(254):117773.
- [8]Lee Jessica G,Jaeger Kathleen E,Seki Yoichi,et al.Human CD36 monocytes induce Foxp3 CD25 T cells with regulatory functions from CD4 and CD8 subsets[J].Immunology,2021,163:293-309.
- [9]Gao YL,Chai YF,Qi AL,et al.Neuropilin-1high CD4+CD25+regulatory T cells exhibit primary negative immunoregulation in sepsis[retracted in:Mediators Inflamm.2020Sep 18;2020:9195623][J].Mediators Inflamm,2016,2016:7132158.
- [10]Reyes M,Filbin MR,Bhattacharyya RP,et al.An immunecell signature of bacterial sepsis[J].Nat Med,2020,26(3):333-340.
- [11]Lee Gap Ryol.The balance of Th17 versus Treg Cells in autoimmunity[J].Int J Mol Sci,2018,19(3):730-743.
- [12]王华兵,童延华,徐玲文,等.CD4+CD25+调节性T细胞/辅助性T细胞17失衡在急性肺损伤小鼠中的作用[J].中华急诊医学杂志,2016,25(7):892-895.
- [13]王华兵,董芳,徐玲文.脓毒症大鼠肠损伤时Treg细胞/Th17细胞的变化[J].中华麻醉学杂志,2020,40(3):366-368.
- [14]洪智勇.从“虚-瘀-毒”论治脓毒症正气虚衰合瘀毒内阻证32例[J].浙江中医杂志,2021,56(1):20-21.
- [15]李志军,王博超.运用“四证四法”辨治感染性休克[J].实用休克杂志(中英文),2017,1(2):73-75.
- [16]张丽君.黄芪甲苷调控Th17/Treg细胞平衡介导抗脓毒症作用机制的研究[D].昆明:云南中医学院,2018.
- [17]郭鸿,尹超,刘丽平,李斌,等.高乌甲素对脓毒症患者Treg/Th17平衡的影响[J].中药药理与临床,2015,31(3):129-131.
- [18]杨敏华,姚友杰,王娟,等.穿心莲内酯对脓毒症大鼠急性心肺组织损伤和炎症反应的影响[J].医药导报,2021,40(4):454-460.
- [19]Lu Jun,Zhang Luyao,Cheng Lu,et al.Xijiao Dihuang decoction improves prognosis of sepsis via inhibition of aerobic glycolysis[J].Biomedicine&Pharmacotherapy,2020(129):42.
- [20]陈怀宇,林名瑞,何绍吾,等.犀角地黄汤对脓毒症大鼠脾脏组织基因表达的影响[J].蛇志,2018,30(1):4-6,12.
- [21]Wang Yuguo,Gao Yue,Feng Jian,et al.Effect of Modified Xijiao Dihuang Decoction(加味犀角地黄汤)on intestinal flora and Th17/Treg in rats with radiation enteritis[J].Chinese Journal of Integrative Medicine,2021,27(3):198-205.
- [22]朱亮,奚耀,赵雷,等.升降散对脓毒症患者Th17/Treg失衡及相关调节因子的干预作用[J].临床急诊杂志,2017,18(6):406-410.
- [23]黄亚秀,李少萍,黄永莲,等.基于Th17/Treg免疫失衡研究茯苓四逆汤对脓毒症心肌病患者的影响[J].深圳中西医结合杂志,2021,31(12):15-18.
- [24]李然,朱晓宁.丹参联合生脉注射液通过IL-23/IL-17轴调节脓毒症患者Treg/Th17失衡作用机制研究[J].中国中医药现代远程教育,2021,19(12):72-74.
- [25]詹雪芳,王振贤,甘惠玲.基于血清Th1/Treg及Th17/Treg轴平衡探讨血必净联合亚胺培南对脓毒症患者免疫功能的影响[J].中药药理与临床,2020,36(6):182-185.
- [26]应天昊,余涛,赵佳宁,等.基于网络药理学研究参附注射液治疗脓毒症的作用机制[J/OL].山东科学,18-27[20021-07-26].
- [27]赵锋利,冼绍祥,罗苑苑,等.参附注射液对脓毒症小鼠免疫调节及炎症因子的影响[J].中国医药导报,2019,16(22):21-25.
- [28]常青,陈豆豆,吴魏芹,等.乌司他丁联合丹红注射液对脓毒症患者的疗效以及对s TREM-1、HBP水平及th17/treg的影响[J].河北医科大学学报,2020,41(8):899-904.
- [29]戴曦.丹红注射液对脓毒症大鼠心肌损伤的保护作用[D].武汉:华中科技大学,2019.